BD-ZADINE (Azacitidine 200mg)

BD-Zadine 200mg Tablet is used in the treatment of some kinds of blood cancer. It is used for the treatment of adult patients with all subtypes of Myelodysplastic Syndrome (MDS). It may be also used to treat other conditions, as determined by the doctor.

Strength200 mg
ManufacturerBDR Pharmaceuticals Internationals Pvt Ltd.
TreatmentKinds of blood cancer
Brand NameBD-ZADINE
Generic NameAzacitidine 200mg)
Country of originMade in India
SKU: 00376 Categories: ,

Description

BD-Zadine 200mg Tablet is used in the treatment of some kinds of blood cancer. It is used for the treatment of adult patients with all subtypes of Myelodysplastic Syndrome (MDS). It may be also used to treat other conditions, as determined by the doctor.

BD-Zadine 200 Tablet can be taken with or without food, but better to have it same time every day. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include vomiting, weakness, nausea, and fever. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.

Additional information

Strength

200 mg

Manufacturer

BDR Pharmaceuticals Internationals Pvt Ltd.

Treatment

Kinds of blood cancer

Brand Name

BD-ZADINE

Generic Name

Azacitidine 200mg)

Country of origin

Made in India

Reviews

There are no reviews yet.

Be the first to review “BD-ZADINE (Azacitidine 200mg)”

Your email address will not be published. Required fields are marked *